Topical skin preparation
A skin preparation combining niacinamide, dipotassium glycyrrhizinate, and heparin-like substances addresses the stickiness issue, offering improved usability and stability through a high-viscosity oil-in-water formulation.
Patent Information
- Application Number
- JP2023210782
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-19
- Filing Date
- 2023-12-14
- Publication Date
- 2024-11-29
AI Technical Summary
Niacinamide-based skin preparations suffer from a sticky feel due to the high concentration required for efficacy, which compromises user experience.
A skin preparation containing 5% or more niacinamide, 0.05% or more dipotassium glycyrrhizinate, and 0.05% or more heparin-like substance, with a viscosity of 3,000 mPa·s or more, providing an oil-in-water type formulation.
The formulation enhances the feel of use by combining niacinamide with dipotassium glycyrrhizinate and heparin-like substances, ensuring excellent spreadability and moisturizing properties while maintaining stability and usability.
Smart Images

Figure 2024167037000001 
Figure 2024167037000002 
Figure 2024167037000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an external skin preparation containing niacinamide, dipotassium glycyrrhizinate, and a heparinoid. [Background technology]
[0002] Niacinamide is known to have whitening, anti-wrinkle, and anti-aging effects, and various skin care products containing niacinamide have been proposed for the purpose of obtaining these effects (Patent Document 1). In order to achieve these effects, it is necessary to incorporate a large amount of niacinamide, but niacinamide has problems with its texture when used, such as being sticky. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] Patent Publication No. 2021-063061 Summary of the Invention [Problem to be solved by the invention]
[0004] Therefore, the present inventors conducted various investigations with the objective of providing an external skin preparation that contains niacinamide and yet has an excellent feel when used. [Means for solving the problem]
[0005] As a result, the inventors have succeeded in developing an external skin preparation that contains niacinamide together with dipotassium glycyrrhizinate and a heparinoid, thereby completing the present invention.
[0006] That is, the present invention is as follows. <1> A skin preparation for external use, comprising (A) 5% by mass or more of niacinamide, (B) dipotassium glycyrrhizinate, and (C) a heparinoid. <2> The content of (B) is 0.05% by mass or more. <1> 2. The topical skin preparation according to claim 1 . <3> The content of (C) is 0.05% by mass or more. <1> 2. The topical skin preparation according to claim 1 . <4> A skin preparation for external use, comprising (A) 5% by mass or more of niacinamide, (B) 0.05% by mass or more of dipotassium glycyrrhizinate, and (C) 0.05% by mass or more of a heparinoid. <5> The composition further contains at least one selected from the group consisting of oils, thickeners, and alcohols. <1> ~ <4> 13. The skin topical preparation according to any one of claims 1 to 12. <6> Characterized by a viscosity of 3,000 mPa·s or more <1> ~ <4> 13. The skin topical preparation according to any one of claims 1 to 12. <7> It is characterized as being oil-in-water <1> ~ <4> 13. The skin topical preparation according to any one of claims 1 to 12. Effect of the Invention
[0007] According to the present invention, by containing a heparinoid and dipotassium glycyrrhizinate together with niacinamide, it is possible to provide an external skin preparation that is excellent in feel when used. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0008] The skin topical preparation of the present invention will be described in detail below. Note that the present invention is not limited to the following embodiments, and may be modified within the scope of what a person skilled in the art can imagine, such as other embodiments, additions, modifications, deletions, etc., and any embodiment is within the scope of the present invention as long as it exhibits the functions and effects of the present invention.
[0009] <(A) Niacinamide> The skin external preparation of the present invention is characterized by containing niacinamide. Niacinamide is an amide of niacin (nicotinic acid / vitamin B3), a water-soluble vitamin that is a type of vitamin B group. In the present invention, niacinamide that is usually used in cosmetics and quasi-drugs can be used, and for example, niacinamide extracted from natural products, purified from them, synthesized by known methods, etc., can also be used as a commercially available product.
[0010] In the skin external preparation of the present invention, niacinamide is blended in the skin external preparation in an amount of 5% by mass or more in order to exert its effect.The upper limit is not particularly limited, but is preferably 30% by mass or less, more preferably 20% by mass or less, and is particularly preferably 10% by mass or less in order to obtain a skin external preparation that is excellent in usability and enjoys the effect of niacinamide.The content of niacinamide in the skin external preparation of the present invention can be analyzed, for example, by high performance liquid chromatography.
[0011] <(B) Dipotassium glycyrrhizinate> The skin topical preparation of the present invention is characterized by containing dipotassium glycyrrhizinate. Dipotassium glycyrrhizinate is a salt of glycyrrhizic acid and potassium. It is also called dipotassium glycyrrhizinate, dipotassium glycyrrhizinate, glycyrrhizinate K2, or glycinone K2, and is a component known to have an anti-inflammatory effect contained in licorice. In the present invention, dipotassium glycyrrhizinate that is usually used in cosmetics and quasi-drugs can be used, and for example, commercially available products such as those extracted from natural products, those purified from natural products, and those synthesized by known methods can also be used.
[0012] The content of dipotassium glycyrrhizinate in the skin external preparation of the present invention is not particularly limited, and is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and from the viewpoint of obtaining a skin external preparation with excellent usability, is particularly preferably 0.05% by mass or more. Also, it is preferably 10% by mass or less, more preferably 5% by mass or less, and particularly preferably 1% by mass or less. The content of dipotassium glycyrrhizinate in the skin external preparation of the present invention can be analyzed, for example, by high performance liquid chromatography.
[0013] <(C) Heparinoids> The skin external preparation of the present invention is characterized by containing a heparinoid. Heparinoids are polysulfated mucopolysaccharides such as chondroitin polysulfate, which are polysulfated polysaccharides having a repeating unit of a disaccharide consisting of D-glucuronic acid and N-acetyl-D-galactosamine, and are known to have moisturizing, anti-inflammatory, and blood circulation promoting effects. In the present invention, the heparinoids can be those normally used in cosmetics and quasi-drugs, and can be commercially available products such as those extracted from natural products, those purified from them, and those synthesized by known methods.
[0014] The content of the heparinoid in the skin external preparation of the present invention is not particularly limited, and is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and from the viewpoint of obtaining a skin external preparation with excellent usability, is particularly preferably 0.05% by mass or more. Also, it is preferably 10% by mass or less, more preferably 5% by mass or less, and particularly preferably 1% by mass or less. The content of the heparinoid in the skin external preparation of the present invention can be analyzed, for example, by high performance liquid chromatography or the organic sulfate group measurement method described in the Japanese Pharmacopoeia Non-Drug Ingredients Standard 2002 Heparinoids Quantitative Method (3).
[0015] <Other ingredients> In addition to the above-mentioned components, the skin external preparation of the present invention may contain other components as necessary. The other components include active ingredients such as oils, thickeners, gelling agents, alcohols, moisturizers, dispersants, plasticizers, spreading agents, preservatives, fragrances, surfactants, film-forming agents, pH adjusters, deodorants, chelating agents, antioxidants, antibacterial agents, antibacterial and antifungal agents, anti-inflammatory agents, and whitening agents, as well as cosmetic and medicinal ingredients such as animal extracts, plant extracts, and vitamins other than niacinamide, and one or more of the components usually used in skin external preparations.
[0016] Among other ingredients, the skin topical preparation of the present invention preferably contains an oily agent. The oily agent that can be used in the present invention is not particularly limited as long as it is one that is usually used in skin topical preparations, but an oily agent that is liquid at 25°C is preferable, and a non-volatile oily agent is particularly preferable. Specific examples of such oils include hydrocarbon oils such as liquid paraffin, squalane, and squalene; fatty acids such as isostearic acid, oleic acid, and polyhydroxystearic acid; higher alcohols such as octyldodecanol and tetradecyldecanol; isopropyl palmitate, isopropyl myristate, isopropyl stearate, isobutyl stearate, 2-ethylhexyl stearate, isopropyl isostearate, butyl isostearate, decyl isostearate, lauryl isostearate, isodecyl isodecanoate, isodecyl isononanoate, isotridecyl isononanoate, isononyl isononanoate, diisostearyl malate, neopentyl glycol dioctanoate, propylene glycol dicaprate, propylene glycol dicaprylate, glyceryl tri-2-ethylhexanoate, monoisopropyl glyceryl tristearate, glyceryl mono ... Examples of the oils include ester oils such as polyglyceryl isostearate, polyglyceryl diisostearate, diglyceryl triisostearate, diglyceryl tetraisostearate, diethyl sebacate, cetyl 2-ethylhexanoate, ethylhexyl palmitate, octyldodecyl myristate, oleyl oleate, ethyl oleate, di(phytosteryl / 2-octyldodecyl) N-lauroyl-glutamate, di(phytosteryl / behenyl / 2-octyldodecyl) N-lauroyl-glutamate, di(cholesteryl / 2-octyldodecyl) N-lauroyl-glutamate, and isopropyl N-lauroyl sarcosine; and silicone oils such as dimethylpolysiloxane, cyclopentasiloxane, and alkoxy-modified polysiloxane. One or more of these oils may be used.
[0017] When an oil agent is blended in the skin external preparation of the present invention, its content is not particularly limited, and is preferably 1% by mass or more, more preferably 3% by mass or more, and from the viewpoint of obtaining a skin external preparation with excellent usability, particularly preferably 5% by mass or more. Also, it is preferably 50% by mass or less, more preferably 40% by mass or less, and particularly preferably 30% by mass or less. In addition, when two or more kinds of oil agents are blended, the content is the total amount of them.
[0018] The skin external preparation of the present invention preferably contains a thickener. The thickener that can be used in the skin external preparation of the present invention is not particularly limited as long as it is a water-soluble component that can be used in cosmetics, external medicines, quasi-drugs, etc., and synthetic polymers, semi-synthetic polymers, natural polymers, clay minerals, etc. can be used.
[0019] Synthetic polymers include hydrophilic synthetic polymers such as carboxyvinyl polymers, polyvinyl alcohol, acrylic acid / alkyl methacrylate copolymers, acrylates / alkyl acrylate crosspolymers, polyacrylic acid, polyacrylamide, polyalkylacrylamide / polyacrylamide copolymers, carboxymethyl cellulose, and cationic cellulose.
[0020] Examples of the semi-synthetic polymer include cellulose derivatives such as carboxymethylcellulose or salts thereof, methylcellulose, ethylcellulose, propylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, sulfonated cellulose derivatives, etc. Other semi-synthetic polymers include propylene glycol alginate, ethylene glycol alginate, dextrin fatty acid ester, gelatin fatty acid ester, gelatin fatty acid amide, etc.
[0021] Examples of natural polymers include polysaccharides and derivatives thereof, such as xanthan gum, succinoglycan, carrageenan, guar gum, locust bean gum, celluloses, galactan, gum arabic, tragacanth gum, tamarind gum, agar, agarose, mannan, curdlan, alginic acid or salts thereof, gum arabic, pectin, quince seed, starch, algae colloid, casein, collagen, gelatin, albumin, fibroin, elastin, keratin, and water-soluble proteins such as sericin.
[0022] Examples of clay minerals include laponite, bentonite, smectite kaolinite, and montmorillonite.
[0023] When the skin external preparation of the present invention contains a thickener, its content is not particularly limited, and is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and from the viewpoint of obtaining a skin external preparation with excellent usability, is particularly preferably 0.1% by mass or more. Also, it is preferably 20% by mass or less, more preferably 15% by mass or less, and particularly preferably 10% by mass or less. In addition, when two or more types of thickeners are contained, it is the total amount.
[0024] In addition, the skin external preparation of the present invention preferably contains alcohols. Examples of alcohols that can be used in the present invention include lower alcohols having 5 or less carbon atoms, such as ethanol and isopropanol; higher alcohols having 6 to 30 carbon atoms, such as cetanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, octyldodecanol, isostearyl alcohol, phytosterol, and cholesterol; dihydric to trihydric polyhydric alcohols, such as propylene glycol (PG), 1,3-butylene glycol (BG), dipropylene glycol, tripropylene glycol, 1,2-pentanediol (pentylene glycol), 1,5-pentanediol, 1,2-hexanediol, 1,2-octanediol, glycerin, and polyethylene glycol; and sugar alcohols, such as sorbitol and xylitol. Among these, in the present invention, it is preferable to use one or more selected from higher alcohols having 6 to 30 carbon atoms and dihydric to trihydric polyhydric alcohols, and it is particularly preferable to use dihydric to trihydric polyhydric alcohols.
[0025] When the skin external preparation of the present invention contains alcohol, its content is not particularly limited, and is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and from the viewpoint of obtaining a skin external preparation with excellent usability, is particularly preferably 1% by mass or more. Also, it is preferably 50% by mass or less, more preferably 40% by mass or less, and particularly preferably 35% by mass or less. In addition, when two or more kinds of alcohol are contained, it is the total amount.
[0026] <External skin preparations> The skin topical preparation of the present invention is a composition that is applied to the skin for use. The skin topical preparation of the present invention preferably has a high viscosity, preferably 500 mPa·s or more, more preferably 1,000 mPa·s or more, and from the viewpoint of excellent usability, particularly preferably 3,000 mPa·s or more. The viscosity of the skin topical preparation of the present invention can be measured, for example, with a B-type viscometer (Brookfield rotational viscometer, temperature: 25°C, rotation speed: 5 rpm).
[0027] The pH of the topical skin preparation of the present invention is preferably 3 to 9, and from the viewpoint of excellent usability, more preferably 4 to 8.5. The pH of the topical skin preparation of the present invention can be measured, for example, by the glass electrode method using a pH meter.
[0028] The skin topical preparation of the present invention can be used in medicines, quasi-drugs, and cosmetics, and can be used in skin care cosmetics such as lotions, milky lotions, creams, serums, gels, etc. Among these, the skin topical preparation of the present invention is preferably a milky lotion, cream, serum, or gel, and more preferably an oil-in-water type milky lotion, cream, serum, or gel.
[0029] The skin external preparation of the present invention can be produced according to a conventional method.For example, when obtaining an oil-in-water composition, prepare an aqueous phase by uniformly dispersing (A) niacinamide, (B) dipotassium glycyrrhizinate, (C) heparinoid, and optionally moisturizer, thickener, emulsifier, etc. in water, add pre-homogenized oil, uniformly emulsify with a homogenizer, etc., and adjust pH as necessary to obtain the skin external preparation of the present invention. EXAMPLES
[0030] The present invention will be described below based on examples, but the present invention is not limited to these examples and can take various forms. The amount of each component used in the examples is in mass % unless otherwise specified.
[0031] <Preparation of topical skin preparation> According to Table 1, the oil-in-water type gel-type skin preparations for external use of Examples 1 to 9 were prepared by the following method. Specifically, (A), (B), (C), 1,3-butylene glycol, glycerin, phenoxyethanol, carboxyvinyl polymer, polysorbate 60, and glyceryl stearate were uniformly dispersed in water to prepare an aqueous phase, and homogenized squalane and ethylhexyl palmitate were added and emulsified uniformly using a homomixer. Then, the pH was adjusted using sodium hydroxide or citric acid.
[0032] [Table 1]
[0033] <Stability measurement of topical skin preparations> (1) Viscosity measurement The viscosity of the obtained topical skin preparation was measured at the time of manufacture (day 0) and after storage at 40°C for 90 days after manufacture using a B-type viscometer (Brookfield RVT model, temperature: 25°C, rotation speed: 5 rpm). The absolute value of the rate of change from the time of manufacture after storage for 90 days was calculated using the following formula. The smaller the absolute value, the smaller the viscosity change and the higher the stability. The results are shown in Table 2.
[0034]
number
[0035] (2)pH measurement The pH of the obtained skin topical preparation was measured using a pH meter (Horiba, Ltd. pH meter F71 type) at the time of manufacture (day 0) and after storage at 40°C for 90 days after manufacture. The absolute value of the rate of change from the time of manufacture after storage for 90 days was calculated using the following formula. The smaller the absolute value, the smaller the pH change and the higher the stability. The results are shown in Table 2.
[0036]
number
[0037] (3) Presence or absence of precipitation The obtained skin topical preparation was observed for its condition after storage. Specifically, it was stored at 5° C. for 90 days, and the presence or absence of precipitation was visually confirmed. The results are shown in Table 2.
[0038] <Evaluation of topical skin preparations> (1) Evaluation of usability The obtained skin topical preparation was evaluated for usability. Samples used were those at the time of manufacture (day 0). Five subjects in their 20s to 30s who had experience using all-in-one gels were randomly selected as test subjects. The skin topical preparation was applied to the test subjects' faces, and the usability (ease of spreading when applied, moist feeling) was used as an evaluation item to comprehensively judge the usability, and a questionnaire was administered based on a five-point rating scale. The average value of each item in the questionnaire was calculated and evaluated. (Good spreadability when applied) 5: Very good (smooth and stretchy) 4: Good (good stretch) 3: Neither (stretches to a degree that is not noticeable when in use) 2: Bad (Poor stretchiness, bothersome when using) 1: Very poor (very poor stretch, not suitable for use) (Moisturizing feeling after application) 5: Very good (very moisturizing after application) 4: Good (moisturizes after application) 3: Neither (Feels slightly moist after application) 2: Poor (hardly any moist feeling after application) 1: Very bad (no moist feeling after application, not suitable for use)
[0039] [Table 2]
[0040] Examples 1 to 9, which are external skin preparations of the present invention, all had a pH of 4 to 8 and a viscosity of 3000 to 35000. In addition, the rate of change in viscosity after storage at 40°C for 90 days was small at less than 10%, and the rate of change in pH was also 5% or less. In addition, no precipitation occurred even after storage at 5°C for 90 days, and the external skin preparations of Comparative Examples 1 to 3 had excellent stability. On the other hand, in Comparative Examples 1 to 4, the change in viscosity after storage at 40°C for 90 days was large at 45% or more, and the change in pH was also large. Furthermore, precipitation occurred at 5°C in Comparative Example 1, and the external skin preparations of Comparative Examples 1 to 3 had poor stability.
[0041] In addition, all of the skin topical preparations of the present invention were excellent in feel when used. The skin topical preparations of Examples 1 to 9 spread well when applied, were moisturized after application, and had an excellent feel when used, compared to the skin topical preparations of Comparative Examples 1 to 4. The good spreadability of the skin topical preparations of Examples 1 to 9 when applied was maintained even after storage at 40°C for 90 days.
[0042] From the above, it is understood that the skin preparation of the present invention is an excellent skin preparation in terms of usability, such as good spreadability when applied and moist feeling after application. Furthermore, it is understood that the skin preparation of the present invention is not only excellent in usability, but also excellent in storage stability.
[0043] <Preparation of topical skin preparation> The oil-in-water type gel-type topical skin preparations shown in Tables 3 and 4 were prepared in the same manner as in the Examples. The obtained topical skin preparations all had a viscosity of 5,000 mPa s or more, a pH of 5 to 8, and were easy to apply when used and had a moist feeling after use, making them excellent in terms of usability.
[0044] [Table 3]
[0045] [Table 4] [Industrial Applicability]
[0046] The topical skin preparation of the present invention contains niacinamide, dipotassium glycyrrhizinate, and a heparinoid, and thus provides a topical skin preparation that is excellent in feel when used, and has high potential for industrial application.
Claims
1. A skin preparation for external use, comprising (A) 5% by mass or more of niacinamide, (B) dipotassium glycyrrhizinate, and (C) a heparinoid.
2. 2. The skin topical preparation according to claim 1, characterized in that the content of (B) is 0.05% by mass or more.
3. 2. The skin topical preparation according to claim 1, characterized in that the viscosity is 3,000 mPa·s or more.
4. 2. The skin topical preparation according to claim 1, which is an oil-in-water type.
Citation Information
Patent Citations
Topical skin preparation for improving wrinkles
JP2021063061A
